Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Bayer MaterialScience strengthens position in carbon nanotubes

Abstract:
Greater freedom for development of new areas of application:
Bayer MaterialScience strengthens position in carbon nanotubes
License agreement with U.S.-based company Hyperion concluded

Bayer MaterialScience strengthens position in carbon nanotubes

Leverkusen/Cambridge, MA | Posted on March 16th, 2011

Bayer MaterialScience is strengthening its position in developing new areas of application for carbon nanotubes (CNT). The company concluded a patent license agreement for the use of these materials with U.S. based company Hyperion Catalysis International, Inc. The agreement will help to solidify the leading positions of both companies in research and development as well as production technology for high-quality CNT-based products. Financial terms were not disclosed.

"We see high demand for materials with extraordinary material properties," said Dr. Joachim Wolff, Member of the Executive Committee at Bayer MaterialScience. "Developments using Baytubes® carbon nanotubes represent a key technology of the future for such requirements profile, and we are optimistic that we can offer our customers innovative and long-term solutions in these areas."

Baytubes® carbon nanotubes can be used as additives in established materials such as plastics and metal. They are versatile due to their unique property profile - from enhanced electrical and thermal conductivity to exceptional mechanical load bearing capacity. Among other things, Baytubes® CNT can help to increase endurance and efficiency of lithium-ion batteries, which in turn opens up their strong potential for use in energy-efficient electro-mobility concepts.

As one of the world's leading manufacturers of polymers and high-performance plastics, Bayer MaterialScience recognized the huge potential of nanotechnology early on. It has carried out intensive research into carbon nanotube production processes. Based in Cambridge, Massachusetts, U.S.A., Hyperion has been active in the field of carbon nanotubes since 1983 and currently holds a comprehensive portfolio of patents and patent applications covering a broad technology range, from CNT manufacturing to a variety of current and future applications.

David M. Wohlstadter, Hyperion's Vice President of Business Development stated, "We are quite pleased to have entered into this arrangement with Bayer MaterialScience. This license with BMS will further leverage Hyperion's broad patent portfolio and capitalize on the ever increasing demand for carbon nanotubes. We feel Bayer MaterialScience is well positioned to serve and help increase this demand, while Hyperion remains committed to expanding its own sales and providing its customers with the highest quality carbon nanotube based products."

####

About Bayer MaterialScience
With 2010 sales of EUR 10.2 billion, Bayer MaterialScience is among the world’s largest polymer companies. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction and the sports and leisure industries. At the end of 2010, Bayer MaterialScience had 30 production sites and employed approximately 14,400 people around the globe. Bayer MaterialScience is a Bayer Group company.

About Hyperion Catalysis International, Inc.:
Headquartered in Cambridge, Massachusetts, U.S.A., Hyperion has been manufacturing and marketing its FIBRIL™ carbon nanotubes for a wide range of applications since 1983. The flagship FIBRIL™ technology is a conductive, multi-walled CNT based on the pioneering work in this field by Dr. Howard G. Tennent. Hyperion has devoted substantial resources to the development, improvement and patenting of the technology of their manufacture and the use of carbon nanotubes in a variety of applications.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

For more information, please click here

Contacts:
Bayer MaterialScience AG
Stefan Paul Mechnig
Tel. +49 214 30-36352

Copyright © Bayer MaterialScience

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

MRI, on a molecular scale: Researchers develop system that could one day peer into the atomic structure of individual molecules April 20th, 2014

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Nanotubes/Buckyballs

Effects of Carbon Nanotubes Studied on Pregnant Mothers April 12th, 2014

Nanotech Business Review 2013-2014 April 9th, 2014

Scientists Succeed in Simultaneous Determination of Acetaminophen, Codeine in Drug Samples April 9th, 2014

Rebar technique strengthens case for graphene: Rice University lab makes hybrid nanotube-graphene material that promises to simplify manufacturing April 7th, 2014

Announcements

MRI, on a molecular scale: Researchers develop system that could one day peer into the atomic structure of individual molecules April 20th, 2014

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Patents/IP/Tech Transfer/Licensing

Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014

Nanoparticles cause cancer cells to self-destruct April 3rd, 2014

A*STAR's Simtech collaboration agreements to accelerate the growth and development of the microfluidics industry April 1st, 2014

Dolomite releases novel droplet-on-demand sequencing and droplet generation microfluidic system April 1st, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE